Related Experiment Video
Updated: Jun 25, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Neuronal Circuit Dysfunction in Amyotrophic Lateral Sclerosis.
Andrea Salzinger1,2, Vidya Ramesh1,2, Shreya Das Sharma1,2
1UK Dementia Research Institute, University of Edinburgh, Edinburgh EH16 4SB, UK.
Amyotrophic Lateral Sclerosis (ALS) damages the corticospinal motor circuit, affecting upper motor neurons (UMNs) and lower motor neurons (LMNs). Research explores mechanisms of motor circuit dysfunction and potential treatments using stem cell models.
Area of Science:
- Neuroscience
- Neurology
- Cell Biology
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease primarily affecting the corticospinal motor circuit.
- The disease involves the loss of upper motor neurons (UMNs) and lower motor neurons (LMNs), leading to muscle atrophy and movement impairment.
- Current disease-modifying treatments for ALS remain limited despite extensive research.
Purpose of the Study:
- To review current research on the mechanisms of corticomotor circuit dysfunction in ALS.
- To summarize knowledge on UMN and LMN dysfunction, neuromuscular junction degeneration, and glial cell roles in ALS.
- To highlight the utility of human stem cell models in studying ALS neural circuit pathology.
Main Methods:
- Review of patient studies.
- Analysis of rodent models of ALS.
- Examination of human stem cell models for ALS research.
Main Results:
- Corticomotor circuit dysfunction is central to ALS pathophysiology.
- Key aspects include UMN degeneration, LMN hyperexcitability, neuromuscular junction deficits, and non-cell autonomous glial contributions.
- Human stem cell technologies offer advanced platforms for modeling complex neural circuits in ALS.
Conclusions:
- Understanding motor circuit dysfunction is crucial for developing ALS therapies.
- Human stem cell models provide valuable insights into ALS mechanisms.
- Further research using these models can accelerate the development of effective treatments for ALS.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Cross-bridge Cycle
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Lysosomal Hydrolases

